Last updated: March 15, 2025
Sponsor: Hadassah Medical Organization
Overall Status: Active - Recruiting
Phase
N/A
Condition
Sexually Transmitted Diseases (Stds)
Vaginitis
Gynecological Infections
Treatment
chlorhexidine gluconate 4%
Clinical Study ID
NCT05963711
0463-22-HMO
Ages > 18 Male Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
The subject has s female partner who participates in VMT study ( NCT04517487).
The subject is defined by the woman as her male regular partner.
Willing to use a condom as instructed by the protocol.
Willing to comply with decolonization protocol.
Exclusion
Exclusion Criteria:
A known skin disease involving the penile skin.
A known sensitivity to chlorhexidine gluconate
Any of the partners (female/male) has more than one sexual partner.
Study Design
Total Participants: 100
Treatment Group(s): 1
Primary Treatment: chlorhexidine gluconate 4%
Phase:
Study Start date:
October 17, 2022
Estimated Completion Date:
June 30, 2026
Connect with a study center
Hadassah Medical Center
Jerusalem,
IsraelActive - Recruiting

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.